Session information

Oral Presentation

[30-211-am] Biomolecules /Others

Sat. Mar 30, 2024 10:45 AM - 11:45 AM [Room 211] Conference Center 211+212 (2F)

Chair: Takashi Sato, Hideyuki Takeuchi

+Add all to schedule

10:45 AM - 10:57 AM

[30-211-am11] Structural comparisons of binding-modes of four anti-NASH drugs to PPARα/δ/γ ligand-binding domains revealed by X-ray crystallography

○Shotaro Kamata¹, Akihiro Honda¹, Chihiro Kaneko¹, Ayane Fujita¹, Saeka Miyawaki¹, Kentaro Watase¹, Yuna Komori¹, Ayumi Shimamura¹, Kiyoka Yashiro¹, Isao Ishii¹ (1. Showa Pharm. Univ.)

10:57 AM - 11:09 AM

[30-211-am12] Inhibition of Metal-dependent Protein Aggregation by Cyclic Polyamine Derivatives for Promoting Oxidative Folding

○Keita Mori¹, Tomohide Saio², Takahiro Muraoka^1,3 (1. Grad. Sch. of Eng., Tokyo Univ. of Agri. and Tech., 2. Inst. of Adv. Med. Sci., Tokushima Univ., 3. KISTEC)

11:09 AM - 11:21 AM

[30-211-am13S] Effect of L-Theanine Administration on Urinary Glucose Excretion in Mice.

○Shinnosuke Yamaura¹, Nano Nakanishi¹, Kenshin Itou¹, Reiko Konishi¹, Akira Mukai¹, Kinjo Toshihiko¹, Kyosuke Uno¹, Nobuyuki Kuramoto¹, Koji Komori¹, Kou Kawada¹ (1. Faculty of Pharm. Sci., Setsunan Univ.)

11:21 AM - 11:33 AM

[30-211-am14] Adipocytes induce tamoxifen resistance in estrogen receptor-positive breast cancer

○Masatoshi Nakatsuji¹, Ko Fujimori¹ (1. Pharm. Sci., Osaka Med. Pharm. Univ.)

11:33 AM - 11:45 AM

[30-211-am15] Development of HER2 antigen-degrading Trastuzumab and the immunological and biochemical features.

○Emi Hifumi^1,2, Moe Tsujita³, Hiroaki Taguchi⁴, Taizo Uda^1,5 (1. Institute for Research Management, Oita University, 2. Research Center for GLOBAL LOCAL Infectious Diseases, Oita University, 3. Graduate School, Oita University, 4. Suzuka University of Medical Science, 5. Information Technologies, and Nanotechnologies (ISIT))